X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7052) 7052
Publication (656) 656
Book Chapter (47) 47
Book Review (41) 41
Conference Proceeding (19) 19
Dissertation (17) 17
Government Document (4) 4
Magazine Article (4) 4
Data Set (2) 2
Streaming Video (2) 2
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
osteoprotegerin (4524) 4524
humans (3831) 3831
index medicus (3406) 3406
animals (2748) 2748
female (2287) 2287
male (2182) 2182
mice (1750) 1750
osteoporosis (1489) 1489
rankl (1413) 1413
receptor activator (1378) 1378
middle aged (1306) 1306
expression (1211) 1211
rank ligand - metabolism (1210) 1210
rank ligand (1169) 1169
osteoprotegerin - metabolism (1161) 1161
endocrinology & metabolism (1133) 1133
adult (1008) 1008
aged (949) 949
osteoprotegerin ligand (942) 942
kappa-b ligand (896) 896
cells, cultured (887) 887
differentiation (866) 866
receptor activator of nuclear factor-kappa b (824) 824
osteoclast differentiation (816) 816
osteoclasts - metabolism (794) 794
cells (787) 787
osteoclastogenesis (758) 758
bone (739) 739
osteoprotegerin - genetics (728) 728
musculoskeletal diseases (725) 725
osteoprotegerin - blood (721) 721
ligand (717) 717
bone resorption (716) 716
cell biology (715) 715
rats (705) 705
gene expression (687) 687
trance protein (685) 685
osteoclasts (661) 661
osteoclasts - cytology (656) 656
osteoblasts (628) 628
osteoclast (626) 626
osteoclasts - drug effects (625) 625
biochemistry & molecular biology (622) 622
osteoblasts - metabolism (617) 617
rank ligand - genetics (612) 612
cytokines (605) 605
dentistry, oral surgery & medicine (593) 593
inflammation (585) 585
analysis (581) 581
receptors, tumor necrosis factor (581) 581
opg (574) 574
in-vitro (570) 570
bones (552) 552
bone-resorption (538) 538
dentistry (538) 538
rheumatology (525) 525
postmenopausal women (522) 522
bone density (516) 516
medicine, research & experimental (503) 503
bone and bones - metabolism (491) 491
oncology (485) 485
apoptosis (468) 468
signal transduction (465) 465
biomarkers - blood (464) 464
ligands (462) 462
immunology (460) 460
orthopedics (444) 444
research (443) 443
cell differentiation (437) 437
activation (433) 433
disease (433) 433
osteoclasts - physiology (433) 433
risk factors (433) 433
proteins (425) 425
mice, inbred c57bl (423) 423
rheumatoid-arthritis (418) 418
rank ligand - blood (411) 411
resorption (405) 405
bone loss (402) 402
density (398) 398
nf-kappa-b (394) 394
gene-expression (388) 388
metabolism (388) 388
osteoblasts - drug effects (387) 387
cell differentiation - drug effects (385) 385
enzyme-linked immunosorbent assay (384) 384
cell line (375) 375
physiological aspects (375) 375
immunohistochemistry (373) 373
rna, messenger - metabolism (368) 368
biocompatibility (363) 363
receptor (363) 363
medicine & public health (362) 362
bone-mineral density (358) 358
rank (349) 349
osteogenesis (348) 348
osteoclasts - pathology (343) 343
mineral density (342) 342
research article (342) 342
tumor-necrosis-factor (341) 341
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6897) 6897
Chinese (120) 120
Japanese (88) 88
German (28) 28
Polish (23) 23
French (19) 19
Spanish (16) 16
Korean (13) 13
Russian (12) 12
Italian (6) 6
Portuguese (4) 4
Turkish (3) 3
Czech (2) 2
Hungarian (2) 2
Dutch (1) 1
Persian (1) 1
Romanian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Nature, ISSN 0028-0836, 11/2010, Volume 468, Issue 7320, pp. 103 - 107
RANK ligand (RANKL), a TNF-related molecule, is essential for osteoclast formation, function and survival through interaction with its receptor RANK(1,2).... 
CELL FUNCTION | OSTEOPROTEGERIN-LIGAND | MULTIDISCIPLINARY SCIENCES | MEDROXYPROGESTERONE ACETATE | RECEPTOR | HORMONE REPLACEMENT THERAPY | HUMAN BREAST-TUMORS | OSTEOCLAST DIFFERENTIATION | EXPRESSION | GLAND DEVELOPMENT | TRANSGENIC MICE | Epithelial Cells - metabolism | RANK Ligand - metabolism | Progesterone - administration & dosage | Epithelial Cells - drug effects | Humans | Progestins - adverse effects | Cell Transformation, Neoplastic - chemically induced | Mammary Neoplasms, Experimental - metabolism | Mammary Neoplasms, Experimental - genetics | Breast Neoplasms - metabolism | Lung Neoplasms - secondary | Mammary Neoplasms, Experimental - pathology | Medroxyprogesterone Acetate - adverse effects | Female | Precancerous Conditions - pathology | Receptor Activator of Nuclear Factor-kappa B - metabolism | Disease Models, Animal | 9,10-Dimethyl-1,2-benzanthracene - administration & dosage | Neoplasm Invasiveness | Mice, Inbred C57BL | Epithelial Cells - pathology | Mice, Transgenic | Progesterone - adverse effects | Mammary Neoplasms, Experimental - chemically induced | RANK Ligand - genetics | Animals | RANK Ligand - antagonists & inhibitors | Breast Neoplasms - pathology | Progestins - administration & dosage | Receptor Activator of Nuclear Factor-kappa B - genetics | Cell Proliferation - drug effects | Medroxyprogesterone Acetate - administration & dosage | Mice | Cell Transformation, Neoplastic - drug effects | Precancerous Conditions - prevention & control | Cell Transformation, Neoplastic - pathology | Mammary Tumor Virus, Mouse - genetics | Mammary Tumor Virus, Mouse - physiology | 9,10-Dimethyl-1,2-benzanthracene - adverse effects | Immunohistochemistry | Care and treatment | Usage | Physiological aspects | Breast cancer | Genetic aspects | Research | Progesterone | Tumor proteins | Health aspects | Risk factors | Proteins | Hormone replacement therapy | Rodents | Apoptosis | Index Medicus
Journal Article
Journal of Clinical Periodontology, ISSN 0303-6979, 03/2012, Volume 39, Issue 3, pp. 239 - 248
Background and Objectives The receptor activator of NF‐κB ligand‐osteoprotegerin (RANKL‐OPG) bi‐molecular system is the “bottle‐neck” regulator of... 
gingival crevicular fluid | receptor activator of NF‐κB ligand | diagnostics | receptor activator of NF‐κB ligand/osteoprotegerin ratio | osteoprotegerin | periodontal disease | receptor activator of NF-ÎB ligand/osteoprotegerin ratio | receptor activator of NF-ÎB ligand | receptor activator of NF-?B ligand | DIFFERENTIAL EXPRESSION | osteoprotegerin ratio | NECROSIS-FACTOR-ALPHA | TRANSCRIPTION FACTOR NFATC1 | MESSENGER-RNA | DENTISTRY, ORAL SURGERY & MEDICINE | OSTEOPROTEGERIN LIGAND | RECEPTOR ACTIVATOR | OSTEOCLAST DIFFERENTIATION | KAPPA-B LIGAND | ALVEOLAR BONE DESTRUCTION | Alveolar Bone Loss - metabolism | Biomarkers - metabolism | Lymphocytes - metabolism | Alveolar Bone Loss - therapy | RANK Ligand - metabolism | Humans | Periodontitis - therapy | Diabetes Mellitus - metabolism | Periodontitis - blood | Gingival Crevicular Fluid - chemistry | Biomarkers - blood | Saliva - chemistry | Periodontal Ligament - metabolism | Periodontitis - metabolism | Dental Plaque - microbiology | Smoking - metabolism | RANK Ligand - blood | Animals | Gingiva - chemistry | Osteoporosis - metabolism | Osteoprotegerin - blood | Osteoprotegerin - metabolism | Osteoblasts - metabolism | Alveolar Bone Loss - blood | Oral hygiene | Immune system | Diabetes mellitus | biomarkers | Blood | Osteoprotegerin | Bone resorption | Osteoclastogenesis | Periodontal diseases | NF- Kappa B protein | Molecular modelling | Periodontitis | Gingiva | TRANCE protein | Saliva | Smoking
Journal Article
Journal Article
Journal of Bone and Mineral Research, ISSN 0884-0431, 02/2009, Volume 24, Issue 2, pp. 182 - 195
Journal Article
Journal of Vascular Research, ISSN 1018-1172, 06/2014, Volume 51, Issue 2, pp. 118 - 131
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2010, Volume 55, Issue 19, pp. 2049 - 2061
Journal Article
Arteriosclerosis, Thrombosis, and Vascular Biology, ISSN 1079-5642, 04/2006, Volume 26, Issue 4, pp. 857 - 863
OBJECTIVE—Based on its role in inflammation and matrix degradation, we hypothesized a role for osteoprotegerin (OPG), RANK, and RANK ligand (RANKL) in coronary... 
Arteriosclerosis | Inflammation | Plaque stability | HEART-FAILURE | ATHEROSCLEROSIS | COMMON VARIABLE IMMUNODEFICIENCY | SERUM OSTEOPROTEGERIN LEVELS | PATHOGENESIS | arteriosclerosis | TUMOR-NECROSIS-FACTOR | inflammation | plaque stability | BIOLOGY | RECEPTOR ACTIVATOR | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | KAPPA-B LIGAND | ARTERY-DISEASE | Receptor Activator of Nuclear Factor-kappa B | Apolipoproteins E - deficiency | Membrane Glycoproteins - metabolism | Muscle, Smooth, Vascular - metabolism | Humans | Middle Aged | Glycoproteins - metabolism | Male | Monocytes - metabolism | RANK Ligand | Osteoprotegerin | Angina, Unstable - immunology | T-Lymphocytes - metabolism | Receptors, Tumor Necrosis Factor - blood | Adult | Female | T-Lymphocytes - pathology | Receptors, Tumor Necrosis Factor - metabolism | Angina, Unstable - metabolism | Cell Line | Atherosclerosis - pathology | Atherosclerosis - immunology | Rupture, Spontaneous - metabolism | Glycoproteins - blood | Rupture, Spontaneous - immunology | Atherosclerosis - metabolism | Mice, Knockout | Muscle, Smooth, Vascular - pathology | Receptors, Cytoplasmic and Nuclear - blood | Angina, Unstable - pathology | Animals | Carrier Proteins - metabolism | Apolipoproteins E - genetics | Aged | Mice | Matrix Metalloproteinases - metabolism | Receptors, Cytoplasmic and Nuclear - metabolism
Journal Article
Journal Article
13.